Supreme Court Protects Preclinical Pharmaceutical Research
Tthe United States Supreme Court has made clear that broad immunity from patent infringement exists for preclinical research and experimentation reasonably related to the process of developing information required for submission to the FDA. This...(Continue Reading)
Biotech Research Tool Patents: The Good, The Bad, and Freely Available?
Recent patent appeals court cases have strengthened the protection afforded by research tool patents. This article from Testa, Hurwitz & Thibeault LLP's Michael H. Brodowski reviews recent case law in research tool patents and strategies to maintain...(Continue Reading)
Companies: I-K
Biotech/Biomedical Companies, from your About.com Guide...(Continue Reading)
Companies: U-Z
Biotech/Biomedical Companies, from your About.com Guide...(Continue Reading)
Patent Protection: How Much is Too Much?
With scores of drug patents expiring, pioneer firms are aggressively trying to maintain their market exclusivity. In the past, numerous companies have been found guilty of using noncompetitive practices (eg. patenting pill shapes and colors) to exclu...(Continue Reading)
Orphan Drugs Designated in 2003
Article lists the drugs and treatments given orphan drug designation by the U.S. FDA in 2003, with links to more information....(Continue Reading)
|
